Genital Neoplasms, Female Clinical Trial
Official title:
A Phase I Study of CCI-779 (Temsirolimus) in Combination With Topotecan in Patients With Gynecologic Malignancies
The aim of the trial is to determine the recommended phase II dose of weekly intravenous topotecan in combination with a fixed dose (25 mg or 15 mg) of weekly intravenous temsirolimus in patients with and without prior pelvic radiation.
n/a
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05051696 -
Intra-tumor Injection of Oncolytic Viruses H101 Combined With or Without Radiotherapy in Refractory/Recurrent Gynecological Malignancies
|
Phase 2 | |
| Completed |
NCT00377520 -
A Trial for Patients With Advanced/Recurrent Endometrial Cancer
|
Phase 2 | |
| Recruiting |
NCT04566952 -
Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer
|
Phase 2 | |
| Completed |
NCT02182245 -
Dose Escalation Study of BIBF 1120 in Patients With Advanced Gynaecological Malignancies
|
Phase 1 | |
| Completed |
NCT00121030 -
Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy
|
Phase 2 | |
| Completed |
NCT00191646 -
An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy
|
Phase 3 | |
| Recruiting |
NCT04556071 -
Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer
|
Phase 2 | |
| Completed |
NCT04679675 -
Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial
|
N/A | |
| Terminated |
NCT00332280 -
Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05360459 -
Characterization of the Intestinal and Vaginal Microbiota in Long-term Survivors of Gynecological Cancer
|
||
| Not yet recruiting |
NCT04807166 -
Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer
|
Phase 2 | |
| Completed |
NCT02966327 -
Effect of Early Compression and Exercise on Lymphedema Incidence in Patients With Gynecological Cancer
|
N/A | |
| Completed |
NCT01654458 -
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
|
N/A | |
| Completed |
NCT02609880 -
Cognitive Behavioral Effects on Sleep, Pain, and Cytokines in Gynecologic Cancer
|
N/A | |
| Completed |
NCT00191607 -
A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.
|
Phase 3 | |
| Terminated |
NCT02499952 -
Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors
|
Phase 2 | |
| Terminated |
NCT01032447 -
Overcoming Obstacles to Clinical Trials Enrollment Through a Navigator Program
|
N/A | |
| Recruiting |
NCT02781155 -
Limiting Chemotherapy Side Effects by Using Moxa
|
Phase 1/Phase 2 | |
| Recruiting |
NCT00391664 -
Questionnaire Study for Gynecological Cancer Survivors
|
N/A | |
| Completed |
NCT00190983 -
A Trial for Patients With Advanced/Recurrent Cervical Cancer
|
Phase 2 |